Bay 55-9837 TFA is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 TFA may be a useful therapy for the research of type 2 diabetes[1].
Molecular Weight:
3854.06
Formula:
C167H270N52O46.C2HF3O2
Target:
GCGR
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted